Related Experiment Video

Updated: May 25, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses

Johan Garaude1, Andrew Kent, Nico van Rooijen

  • 1Immunology Institute, Department of Medicine, The Tisch Cancer Institute, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA.

Science Translational Medicine
|February 11, 2012
PubMed

Insights

Introducing microbial flagellin into tumor cells activates Toll-like receptor 5 (TLR5) and Nod-like receptors (NLRs) for potent anticancer immunity. This dual activation enhances T cell priming and tumor suppression, offering a novel cancer vaccine strategy.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Toll-like receptor (TLR) ligands are explored as adjuvants in cancer vaccines to stimulate innate immunity and antitumor responses.
  • Challenges remain in enhancing tumor antigen presentation, promoting protective immunity, and overcoming the immunosuppressive tumor microenvironment.

Purpose of the Study:

  • To investigate the efficacy of expressing the TLR ligand flagellin within tumor cells as an antitumor vaccination strategy.
  • To elucidate the roles of TLR5 and Nod-like receptors (NLRs) in flagellin-mediated antitumor immune responses.

Main Methods:

  • Tumor cells engineered to express flagellin were used for vaccination studies.
  • In vivo experiments assessed tumor cell clearance, T cell priming (CD4+ and CD8+), tumor growth suppression, and protective immunization.
  • Genetic disruption of flagellin recognition pathways (TLR5, NLRC4/NAIP5) was employed to determine their necessity.

Main Results:

  • Flagellin expression in tumor cells led to simultaneous engagement of TLR5 and NLRs (NLRC4/NAIP5) for optimal antigen presentation.
  • TLR5 signaling was crucial for rapid macrophage-dependent tumor cell clearance.
  • Both TLR5 and NLRC4/NAIP5 were essential for priming antitumor T cells and suppressing tumor growth; disruption impaired vaccine efficacy.

Conclusions:

  • Engineering tumor cells to express flagellin is a viable strategy for inducing potent anticancer immune responses.
  • This approach leverages microbial structures with dual TLR and NLR stimulatory activity to enhance tumor antigen recognition and activate innate immune pathways.
  • The findings present a novel strategy for cancer vaccines that integrates microbial pattern recognition with tumor antigen presentation for effective antitumor immunity.

More Related Videos

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview